IDO1: An important immunotherapy target in cancer treatment
Year: 2017
Type: review
Source: International Immunopharmacology
Authors: Fangxuan Li, Rupeng Zhang, Shixia Li, Juntian Liu
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2602892158
